<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Taibah Univ Med Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">J Taibah Univ Med Sci</journal-id>
<journal-title-group>
<journal-title>Journal of Taibah University Medical Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1658-3612</issn>
<publisher>
<publisher-name>Taibah University</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31435241</article-id>
<article-id pub-id-type="pmc">6695077</article-id>
<article-id pub-id-type="publisher-id">S1658-3612(17)30057-4</article-id>
<article-id pub-id-type="doi">10.1016/j.jtumed.2017.04.003</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetics of human diseases and scope in future therapeutics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shamsi</surname>
<given-names>Monis B.</given-names>
</name>
<degrees>Ph.D.</degrees>
<email>monisbilalshamsi@gmail.com</email>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
<xref ref-type="fn" rid="fn1">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Firoz</surname>
<given-names>Abdul S.</given-names>
</name>
<degrees>M.Sc.</degrees>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="fn" rid="fn1">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Imam</surname>
<given-names>Syed N.</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alzaman</surname>
<given-names>Naweed</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Samman</surname>
<given-names>Muhammad A.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="aff1">a</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>a</label>Center for Genetics &amp; Inherited Diseases, Taibah University, Almadinah Almunawwarah, KSA</aff>
<aff id="aff2"><label>b</label>Department of Anatomy, College of Medicine, Taibah University, Almadinah Almunawwarah, KSA</aff>
<aff id="aff3"><label>c</label>Department of Internal Medicine, College of Medicine, Taibah University, Almadinah Almunawwarah, KSA</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding address: Center for Genetics &amp; Inherited Diseases, Taibah University, Prince Abdul Mohsin Road, Almadinah Almunawwarah 42013, KSA. <email>monisbilalshamsi@gmail.com</email></corresp>
<fn id="fn1">
<label>d</label>
<p id="ntpara0015">Contributed equally.</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>22</day>
<month>5</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>3</issue>
<fpage>205</fpage>
<lpage>211</lpage>
<history>
<date date-type="received">
<day>31</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 The Authors</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0015">
<p>Epigenetics is the study of nucleotide modifications that are heritable and act as regulatory mechanisms without changing the nucleotide sequence of the genome. Exogenous cues such as environment, lifestyle, nutrition, stress, and psychological factors affect epigenetic mechanisms. This mechanism is in concordance with the genetic information that plays an important role during prenatal and postnatal life of an individual. Recent epigenetic studies have revealed the potential of epigenetics in elucidating the mechanisms of different diseases. In this review, we discuss basic epigenetic mechanisms and their roles in health and disease. In addition, reported aberrations in epigenetic regulation for some common human diseases are described. Finally, we address some epigenetic approaches that have shown potential for targeted treatment of diseases.</p>
</abstract>
<trans-abstract xml:lang="ar">
<title>الملخص</title>
<p>علم التخَلُّق هو دراسة التعديلات النوكليوتيدية المورَّثة التي تعمل كآلية تنظيمية دون تغيير التسلسل النيوكليوتيدي للجينوم. تؤثر إشارات خارجية مثل البيئة، ونمط الحياة، والتغذية، والإجهاد والعوامل النفسية على آليات التخَلُّق. وتتوافق هذه الآلية مع المعلومات الجينية التي تلعب دورا مهما في حياة الفرد قبل الولادة وبعدها. لقد كشفت الدراسات الأخيرة في علم التخَلُّق إمكانات علم التخَلُّق في توضيح آليات أمراض مختلفة لم يتم فهمها سابقا بشكل كامل.</p>
<p>ناقشنا في هذا الاستعراض آليات التخَلُّق الأساسية ودورها في الصحة والمرض. إضافة إلى ذلك فقد تم وصف الانحرافات في التنظيم التخلُّقي التي تم تسجيلها لبعض الأمراض البشرية الشائعة. وأخيرا، تتناول الورقة بعض الأساليب في علم التخَلُّق، التي تكمن بها القدرة على العلاج الموجَّه للأمراض.</p>
</trans-abstract>
<kwd-group id="kwrds00125b" xml:lang="ar">
<title>الكلمات المفتاحية</title>
<kwd>علم التخَلُّق</kwd>
<kwd>داء السكري</kwd>
<kwd>السرطان</kwd>
<kwd>اضطراب الطبع</kwd>
<kwd>داء الزهايمر</kwd>
</kwd-group>
<kwd-group id="kwrds0015">
<title>Keywords</title>
<kwd>Alzheimer's disease</kwd>
<kwd>Cancer</kwd>
<kwd>Diabetes</kwd>
<kwd>Epigenetics</kwd>
<kwd>Imprinting disorders</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>Introduction</title>
<p id="p0010">The term ‘epigenetics’ means ‘on top’ or ‘in addition’ to genetics. Epigenetic processes include mitotically and/or meiotically heritable alterations to genetic information without changing the DNA sequence.<xref ref-type="bibr" rid="bib1"><sup>1</sup></xref> Thus, the genome refers to the entire set of genetic information as nucleotide sequence within the DNA, whereas the epigenome refers to complex modifications within genomic DNA.</p>
<p id="p0015">Genetics studies have been widely conducted and have contributed greatly to our understanding of human diseases; however, epigenetics has recently provided new information to decipher the causative mechanisms of many diseases. Epigenetics not only considers the genomic constitution, but also integrates the social and natural environment, influence of everyday routine, dietary habits, and stresses to biological systems. The epigenome integrates information encoded in the genome with molecular and chemical cues of cellular, extracellular, and environmental origin to define the functional identity of each cell type during development or disease.<xref ref-type="bibr" rid="bib2"><sup>2</sup></xref> These stimuli-initiated modulations of the epigenome contribute to embryo development, cell differentiation, and responses to exogenous signals.<xref ref-type="bibr" rid="bib3"><sup>3</sup></xref> Thus, in contrast to the consistency of the genome, plasticity in the epigenome is characterized by dynamic and flexible responses to intracellular and extracellular stimuli including those from the environment.</p>
<p id="p0020">Predominantly, epigenetic modifications include DNA methylation, histone, modifications, and RNA-associated silencing. These modifications in the genome regulate numerous cellular activities, and disruption of these activities may cause abnormal expression or silencing of genes. Aberrations in the epigenome contribute to the aetiology of numerous diseases during both prenatal and postnatal life. Unlike most genetic defects, epigenetic defects are reversible. This reversibility is an important aspect of the epigenetic contribution to diseases and makes such diseases amenable to therapeutics.</p>
<p id="p0025">This review describes the most widely studied epigenetic mechanisms and epigenetic aberrations in some common human diseases. The contribution of epigenetics in human diseases and new treatment options currently being explored are also discussed.</p>
</sec>
<sec id="sec2">
<title>Mechanisms underlying epigenetics</title>
<p id="p0030">The genome within each cell is identical; however, the terminal phenotype is contributed by manifestations of epigenetic markers in the genome that lead to deviations in their gene expression profiles. These deviations are regulated mainly by DNA methylation, as well as modifications of histone and RNA-associated silencing.</p>
<sec id="sec2.1">
<title>DNA methylation</title>
<p id="p0035">DNA methylation takes place at the 5′ position in the pyrimidine ring to covalently link a methyl group (—CH<sub>3</sub> moiety) to the cytosine. A cytosine located prior to guanine in the genome forms CpG sites, which are abundantly present in the promoters of protein-coding genes. Methylation and demethylation of these CpG sites regulate transcription and gene expression. DNA methylation is maintained by a variety of DNA methyltransferases (DNMTs) that are present in biological systems. DNA methyltransferase 1 (DNMT1) maintains normal methylation markers during the trans-generational copying of the methylation pattern from one cell generation to another during cell division. DNMT2 is associated with potential RNA methylation and embryonic stem cells. <italic>De novo</italic> methylation at CpG sites involves DNMT3A and DNMT3B.<xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref></p>
<p id="p0040">The ‘methylome’, i.e. the genomic arrangement of a methylated DNA sequence in a cell, may change in response to environmental stimuli, disease, and developmental stage. 5-Methylcytosine is highly prone to mutations; C:G to T:A transitions lead to CpG methyl acceptor site suppression. Approximately 40% of mammalian genes have stretches of CpGs within their promoter regions; methylation of these sites leads to heritable transcriptional silencing. <italic>De novo</italic> methylation errors at CpGs in the promoter region are indicators of human diseases and have been detected during early tumourigenesis.<xref ref-type="bibr" rid="bib6"><sup>6</sup></xref></p>
</sec>
<sec id="sec2.2">
<title>Histone modifications</title>
<p id="p0045">Histones are core proteins that wrap around DNA to function as a structural backbone at regular intervals during formation of a chromatin complex. The first level of chromatin organization, referred to as the nucleosome, includes histones H2A, H2B, H3, and H4 structured as an octameric core with DNA wrapped tightly around the octamer.<xref ref-type="bibr" rid="bib7"><sup>7</sup></xref></p>
<p id="p0050">Acetylation and methylation of conserved lysine residues at the amino-terminal tail domains of histone are epigenetic modifiers. Epigenetic regulation through histones is mediated by the degree of DNA compaction, which influences transcriptional activity.</p>
<p id="p0055">Histone acetyltransferases and histone deacetylases add/remove acetyl groups on lysine residues in histone tails, as a part of epigenetic regulation. Generally, lysine acetylation on histone tails promotes transcriptional activation by chromatin relaxing, whereas deacetylation promotes chromatin compaction and transcriptional inactivation.</p>
<p id="p0060">Depending upon which amino acid is methylated, histone methylation can activate or inactivate chromatin expression. If lysine 9 in the N-terminus of histone H3 (H3—K9) is methylated, gene expression is suppressed. Heterochromatic regions such as telomeres and centromeres, repressed promoters, and inactive X chromosome are regulated by this mechanism. However, for lysine 4, methylation at histone H3 (H3—K4) promotes gene expression mostly in the promoters of active genes.<xref ref-type="bibr" rid="bib8"><sup>8</sup></xref></p>
</sec>
<sec id="sec2.3">
<title>RNA-associated silencing</title>
<p id="p0065">MicroRNAs (miRNA) and small interfering RNAs play important roles in RNA-associated silencing, during which they downregulate gene expression at the post-transcriptional modification stage. Post-transcriptional binding of non-coding RNA to 3′-untranslated regions of target mRNAs acts as a putative RNA silencing mechanism.<xref ref-type="bibr" rid="bib9"><sup>9</sup></xref> Approximately 30% of genes are targeted by miRNA, representing just 1% of the genome.<xref ref-type="bibr" rid="bib10"><sup>10</sup></xref> These RNAs act as switches and modulators to fine-tune gene expression during normal development and in diseases.<xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref> Additionally, miRNAs play an important role in tumour suppression, apoptosis, cellular proliferation, and cell movement.<xref ref-type="bibr" rid="bib14"><sup>14</sup></xref></p>
</sec>
</sec>
<sec id="sec3">
<title>Epigenetic influences and human diseases</title>
<p id="p0070">Epigenetic abnormalities such as aberrant DNA methylation, histone modifications, or RNA silencing are found in numerous human diseases. Gene mutations that alter the epigenetic profile may also cause pathologies, which can be inherited or acquired somatically.</p>
<p id="p0075">Throughout life, DNA accessibility is epigenetically regulated. In early embryonic stages, histone modifications and demethylation occur in the paternal genome.<xref ref-type="bibr" rid="bib15"><sup>15</sup></xref> The maternal genome also undergoes demethylation, after which embryonic re-methylation is initiated, contributing to the epigenetic profile of the developing embryo. The newly established epigenetic profile must be maintained for efficient gene regulation. Any error in maintenance may contribute to congenital disorders and paediatric syndromes or predispose people to acquired diseases.</p>
<sec id="sec3.1">
<title>Epigenetics of cancer</title>
<p id="p0080">Global DNA hypomethylation and gene-specific hypermethylation have been observed in human cancer cells obtained from clinical tissue biopsies.<xref ref-type="bibr" rid="bib16"><sup>16</sup></xref> During initial studies of cancer epigenetics, the genome of patients with colorectal cancer was reported to be hypomethylated.<xref ref-type="bibr" rid="bib17"><sup>17</sup></xref> In these patients, regions that are hypermethylated under normal conditions and silent regions of the genome were found to be demethylated. In contrast, aberrant gene activity such as repression of tumour-suppressor genes has been associated with hypermethylation of CpG islands in certain cancers.<xref ref-type="bibr" rid="bib18"><sup>18</sup></xref> DNA repetitive sequences such as microsatellites become functionally aberrant and induce tumourigenesis by hypermethylation of DNA.<xref ref-type="bibr" rid="bib19"><sup>19</sup></xref> Jones and Baylin reported that microsatellites in colorectal and ovarian cancers are distorted by abnormal epigenetic modulations in the <italic>MLH1</italic> promoter (a DNA repair gene).<xref ref-type="bibr" rid="bib6"><sup>6</sup></xref></p>
<p id="p0085">In many human cancers, the CpG islands in the promoters of tumour-suppressor genes such as <italic>CDKN2A</italic>, <italic>CDKN2B</italic>, <italic>TP73</italic>, <italic>MLH1</italic>, <italic>APC</italic>, <italic>BRCA1</italic>, <italic>MGMT</italic>, <italic>VHL</italic>, <italic>GSTP1</italic>, <italic>CDH1</italic>, and <italic>DAPK1</italic> have been observed to be hypermethylated.<xref ref-type="bibr" rid="bib16"><sup>16</sup></xref> Promoter hypermethylation<xref ref-type="bibr" rid="bib20"><sup>20</sup></xref> and heterochromatinization<xref ref-type="bibr" rid="bib21"><sup>21</sup></xref> in patients with cancer suggests that epigenetics play a critical role in tumourigenesis.</p>
<p id="p0090">In a study by Kim and Sharpless, <italic>INK4</italic> (a cyclin-dependent kinase inhibitor), was transcriptionally inactivated by hypermethylation at the promoter region.<xref ref-type="bibr" rid="bib22"><sup>22</sup></xref></p>
<p id="p0095"><italic>INK4</italic> encodes several proteins that are frequently targeted during early tumourigenesis, including <italic>p14</italic>, <italic>p15</italic>, and <italic>p16</italic>. Carcinogenic changes have also been reported in abnormal histone modifications. Witcher and Emerson reported that the loss of chromatin domains and discrete histone structures are associated with dysregulation of transcriptional control of <italic>p16</italic> in breast cancer cells.<xref ref-type="bibr" rid="bib23"><sup>23</sup></xref></p>
<p id="p0100">miRNAs, which are short non-coding RNAs (∼21 nucleotides), induce translational repression when they imperfectly align with the 3′-untranslated regions of target mRNAs. Many tumour-suppressive microRNAs such as miR-34a and 34b/c, miR-124, miR-137, miR-152, miR-218, and miR-345 are suppressed by DNA hypermethylation.<xref ref-type="bibr" rid="bib24"><sup>24</sup></xref></p>
</sec>
<sec id="sec3.2">
<title>Epigenetics of neurological disease</title>
<p id="p0105">Recent studies have suggested that neurological diseases are also caused by epigenetic anomalies. Evidence suggests that <italic>de novo</italic> methylation and DNMT maintenance is critical for neuronal function and neurological behaviour. In patients with schizophrenia and bipolar disorder, elevated DNMT1 levels were found in GABAergic neurons.<xref ref-type="bibr" rid="bib25"><sup>25</sup></xref> Further, hypermethylated <italic>GAD67</italic> and <italic>RELN</italic> associated with low transcript levels were observed in cells from patients with neurological diseases.<xref ref-type="bibr" rid="bib25"><sup>25</sup></xref></p>
<p id="p0110">It has been reported that hereditary sensory neuropathy due to <italic>DNMT1</italic> gene mutations are associated with dementia and hearing loss.<xref ref-type="bibr" rid="bib26"><sup>26</sup></xref> Mutations in <italic>DNMT3B</italic> are commonly reported in immunodeficiency-centromeric instability-facial anomalies.<xref ref-type="bibr" rid="bib27"><sup>27</sup></xref> In this condition, hypomethylation at <italic>LHX2</italic>, loss of tri-methylation at histone H3K27 causing gene repression, and gain of H3K9 acetylation and H3K4 trimethylation causing gene activation have been observed<xref ref-type="bibr" rid="bib27"><sup>27</sup></xref>.</p>
<p id="p0115">In Alzheimer's disease, significant DNA hypomethylation in the temporal neocortex has been observed.<xref ref-type="bibr" rid="bib28"><sup>28</sup></xref> In brain tissues from patients with Alzheimer's disease, DNA methylation markers were significantly reduced.<xref ref-type="bibr" rid="bib29"><sup>29</sup></xref> However, a study of blood samples from patients with Alzheimer's disease showed elevated <italic>LINE-1</italic> methylation compared to samples from age-matched controls.<xref ref-type="bibr" rid="bib30"><sup>30</sup></xref></p>
<p id="p0120">In autism, a cumulative effect of genetics (mutations in synaptic factors) and the environment has been suggested. Epigenetics may connect these two contributory factors leading to disease development.<xref ref-type="bibr" rid="bib31"><sup>31</sup></xref> Environmental factors such as stress, maternal care, dietary insufficiencies, drugs, and mental and neuronal stimulation may affect brain function by altering the epigenetic profile of genes.<xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>, <xref ref-type="bibr" rid="bib35">35</xref>, <xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib37">37</xref></p>
</sec>
<sec id="sec3.3">
<title>Epigenetics of autoimmune disorders</title>
<p id="p0125">Studies have confirmed that epigenetic anomalies are also important contributors to autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). SLE is a chronic autoimmune disorder.<xref ref-type="bibr" rid="bib38"><sup>38</sup></xref> Epigenetic changes are influenced by the environment, and dysregulation of related genes may stimulate autoimmunity.<xref ref-type="bibr" rid="bib38">38</xref>, <xref ref-type="bibr" rid="bib39">39</xref> The disease severity of SLE has been reported to be inversely associated with 5-methylcytosine from CD4<sup>+</sup> T lymphocytes of patients.<xref ref-type="bibr" rid="bib40">40</xref>, <xref ref-type="bibr" rid="bib41">41</xref> Similar observations for altered DNA methylation profiles were observed in SLE mouse models. Animal models with mutations affecting the epigenome showed reduced DNA methylation and suppressed <italic>DNMT1</italic> expression in T-cells, which directly correlates with aging and SLE progression.<xref ref-type="bibr" rid="bib42">42</xref>, <xref ref-type="bibr" rid="bib43">43</xref></p>
<p id="p0130">However, little is known regarding the role of histone acetylation abnormalities in SLE. In CD4<sup>+</sup> T lymphocytes of patients with SLE, global histone H3 and H4 hypoacetylation has been reported.<xref ref-type="bibr" rid="bib44"><sup>44</sup></xref> In contrast, histone H4 hyperacetylation at gene promoters was observed in monocytes from patients with SLE.<xref ref-type="bibr" rid="bib45"><sup>45</sup></xref></p>
<p id="p0135">The affected joints of patients with RA contain hyper-reactive synovial cells because of elevated levels of pro-inflammatory cytokines.<xref ref-type="bibr" rid="bib46"><sup>46</sup></xref> Additionally, osteoclasts and rheumatoid arthritis synovial fibroblasts (RASF) in the joints break down bone and cartilage tissues.<xref ref-type="bibr" rid="bib47"><sup>47</sup></xref> In patients with arthritis, global DNA hypomethylation is found in the blood, synovial mononuclear cells, and synovial tissue.<xref ref-type="bibr" rid="bib48"><sup>48</sup></xref> Neidhart et al. reported hypomethylation of RASF in patients with arthritis.<xref ref-type="bibr" rid="bib49"><sup>49</sup></xref> Similar findings were reported by Karouzakis et al., who observed that healthy controls had higher levels of DNMT1 than did patients with arthritis.<xref ref-type="bibr" rid="bib50"><sup>50</sup></xref> Further, they found that the severity of phenotypes of RASF was correlated with DNMT1 and global DNA methylation. In RASFs, <italic>MMP1</italic> promoter hyperacetylation leads to overexpression of this gene.<xref ref-type="bibr" rid="bib51"><sup>51</sup></xref></p>
</sec>
<sec id="sec3.4">
<title>Epigenetics of diabetes</title>
<p id="p0140">Insufficient secretion of insulin from the pancreas results in abnormal blood glucose levels, leading to type 2 diabetes. The findings of numerous studies emphasize the critical role of epigenetic errors in type 2 diabetes. Intrauterine stress prior to or during pregnancy has been reported to increase the susceptibility to diabetes during postnatal life.<xref ref-type="bibr" rid="bib52">52</xref>, <xref ref-type="bibr" rid="bib53">53</xref>, <xref ref-type="bibr" rid="bib54">54</xref>, <xref ref-type="bibr" rid="bib55">55</xref> Intrauterine stress that may adversely affect adaptive physiological and cellular responses in key organs may be attributed to nutritional, environmental, maternal, placental, or genetic factors.<xref ref-type="bibr" rid="bib56"><sup>56</sup></xref> It has been suggested that the susceptibility to metabolic disease during adult life involves <italic>in utero</italic> epigenetic mechanisms influenced by intrauterine stress factors.<xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib58">58</xref></p>
<p id="p0145">Kuroda et al. observed that as compared to non-insulin expressing cell types, the promoter region of insulin-producing beta cells is hypomethylated.<xref ref-type="bibr" rid="bib59"><sup>59</sup></xref> Further, they demonstrated that expression of the insulin gene is negatively associated with DNA methylation at a CpG site located at 182 base pairs upstream of the insulin promoter. Further, H4 hyperacetylation and H3 dimethylation at lysine 4 were reported in patients with type 2 diabetes.<xref ref-type="bibr" rid="bib60">60</xref>, <xref ref-type="bibr" rid="bib61">61</xref> Thus, the expression of epigenetic changes in pancreatic islets and beta cells significantly affects diabetes risk in individuals.</p>
</sec>
<sec id="sec3.5">
<title>Imprinting disorders</title>
<p id="p0150">The epigenetic mechanism regulating gene expression in a parent of origin-specific manner is referred as genomic imprinting. During imprinting, one allele from either parent is expressed while the other is silent (imprinted). Imprinting errors are critical in numerous developmental and paediatric disorders.<xref ref-type="bibr" rid="bib62">62</xref>, <xref ref-type="bibr" rid="bib63">63</xref>, <xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib65">65</xref> DNA methylation and histone modifications regulate the imprinting processes.<xref ref-type="bibr" rid="bib66"><sup>66</sup></xref> Angelman, Prader–Willi, and Beckwith–Wiedemann syndromes are the most common and widely studied imprinting disorders. Epigenetic abnormalities at chromosome 15 on the paternal allele lead to Prader–Willi, whereas epigenetic abnormalities at the same locus on the maternal allele of chromosome 15 cause Angelman syndrome.<xref ref-type="bibr" rid="bib62">62</xref>, <xref ref-type="bibr" rid="bib63">63</xref> The clinical features of Prader–Willi syndrome include developmental delay, neonatal hypotonia, hyperphagia, and hypogonadism. Patients with Prader–Willi syndrome were reported to have maternal uniparental disomy 15q11.2 and hypermethylation of the paternal allele for small nucleolar ribonucleoprotein polypeptide N.<xref ref-type="bibr" rid="bib67">67</xref>, <xref ref-type="bibr" rid="bib68">68</xref>, <xref ref-type="bibr" rid="bib69">69</xref></p>
<p id="p0155">The clinical features of Angelman syndrome includes developmental delay with absent or nearly absent speech, ataxic gait, and seizures. Patients with Angelman syndrome show suppressed maternally expressed ubiquitin-protein ligase E3A and paternal uniparental disomy 15q11.2.<xref ref-type="bibr" rid="bib70">70</xref>, <xref ref-type="bibr" rid="bib71">71</xref></p>
</sec>
</sec>
<sec id="sec4">
<title>Future perspectives</title>
<p id="p0160">Various studies and clinical trials have examined epigenetic therapies which shown the potential to decrease the burden of diseases in which abnormal epigenetic mechanisms play a critical role. Numerous therapeutic agents that can modulate epigenetic mechanisms in various disease conditions are under consideration for clinical use. Azacitidine, a nucleoside analogue that can be incorporated into DNA during replication, inhibits methylation and reactivates a previously silenced gene<xref ref-type="bibr" rid="bib72"><sup>72</sup></xref> and is the compound of choice in most studies. It has been reported to be effective in clinical trials for treating myelodysplastic syndrome and leukaemia.<xref ref-type="bibr" rid="bib73"><sup>73</sup></xref> MG98, an antisense oligonucleotide, was reported to be effective for treating solid tumours and renal cancers<xref ref-type="bibr" rid="bib74"><sup>74</sup></xref> by downregulating DNMT1. Another class of molecules used to treat epigenetic diseases are the histone modifiers ‘histone deacetylase (HDAC) inhibitors’. These molecules inhibit HDAC activity and prevent the removal of acetyl groups from DNA to maintain active gene expression active. Phenylbutyric acid, SAHA, depsipeptide, and valproic acid are the most common HDAC inhibitors.<xref ref-type="bibr" rid="bib75"><sup>75</sup></xref> Amalgamating different epigenetic therapy strategies as demethylating agents and HDAC inhibitors or a combination of epigenetic therapy and chemo- or immunotherapy may have greater efficacy. Such combinations will help to synergistically kill cancer cells by reactivating silenced tumour-suppressor genes and re-sensitizing cells that are resistant to drugs and therefore enhance the response to conventional therapies.<xref ref-type="bibr" rid="bib75">75</xref>, <xref ref-type="bibr" rid="bib76">76</xref>, <xref ref-type="bibr" rid="bib77">77</xref> Additional studies of the therapeutic approach to epigenetic therapy are required, as the procedure is not selective for target cells and activating gene expression in normal cells may make them cancerous. Further insight into the molecular mechanisms governing these epigenetic modulators will facilitate the design of more specific and effective drugs. The development of more specific HDAC inhibitors has shown great promise. Increasing target specificity will also significantly affect the development of more effective treatment options. The approval of two epigenetic drugs (Vidaza and romidepsin, HDAC inhibitors) by the US Food and Drug Administration has supported their use in disease treatment. Additionally, epigenetic profiling of patients may have predictive or prognostic value for epigenetic therapy. Thus, epigenetic biomarkers can be used to complement current strategies for diagnosis, prognosis, and prediction of drug responses and assist with therapeutic decision-making.</p>
</sec>
<sec id="sec5">
<title>Conclusion</title>
<p id="p0165">The findings from various studies clearly suggest that aberrations in the epigenome are critical factors in the initiation and progression of many diseases. Although progress has been made in understanding epigenetic abnormalities, further large-scale epigenetic profiling will lead to a comprehensive and clear understanding of how lifestyle factors, social and psychological attributes, and various other dynamics interact with the naturally inherited genome to affect the predisposition to diseases.</p>
</sec>
<sec id="sec6">
<title>Conflict of interest</title>
<p id="p0170">The authors have no conflict of interest to declare.</p>
</sec>
<sec id="sec7">
<title>Authors' contribution</title>
<p id="p0175">MBS and ASF conceived, designed and carried out the literature study and wrote the full manuscript. MBS, ASF, SNI, NA and MAS critically reviewed and approved the initial submission and the revisions of the manuscript. The authors are responsible for the content of the manuscript.</p>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Issa</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Just</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Epigenetics</article-title>
<source/>FEBS Lett
          <volume>585</volume>
<year>2011</year>
<fpage>1993</fpage>
<pub-id pub-id-type="pmid">21693122</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivera</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Mapping human epigenomes</article-title>
<source/>Cell
          <volume>155</volume>
<year>2013</year>
<fpage>39</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">24074860</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skinner</surname>
<given-names>M.K.</given-names>
</name>
</person-group>
<article-title>Environmental epigenetic transgenerational inheritance and somatic epigenetic mitotic stability</article-title>
<source/>Epigenetics
          <volume>6</volume>
<year>2011</year>
<fpage>838</fpage>
<lpage>842</lpage>
<pub-id pub-id-type="pmid">21637037</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lyko</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Solving the Dnmt2 enigma</article-title>
<source/>Chromosoma
          <volume>119</volume>
<issue>1</issue>
<year>2010 Feb</year>
<fpage>35</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">19730874</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramaniam</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Thombre</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dhar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anant</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>DNA methyltransferases: a novel target for prevention and therapy</article-title>
<source/>Front Oncol
          <volume>4</volume>
<year>2014 May 1</year>
<fpage>80</fpage>
<comment>eCollection 2014</comment>
<pub-id pub-id-type="pmid">24822169</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Baylin</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>The fundamental role of epigenetic events in cancer</article-title>
<source/>Nat Rev Genet
          <volume>3</volume>
<year>2002</year>
<fpage>415</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="pmid">12042769</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mader</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Richmond</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Sargent</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Richmond</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Crystal structure of the nucleosome core particle at 2.8 A resolution</article-title>
<source/>Nature
          <volume>389</volume>
<year>1997</year>
<fpage>251</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="pmid">9305837</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lachner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jenuwein</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>The many faces of histone lysine methylation</article-title>
<source/>Curr Opin Cell Biol
          <volume>14</volume>
<year>2002</year>
<fpage>286</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="pmid">12067650</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Pal Bhadra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Girschick</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>Micro-RNA- micro in size but macro in function</article-title>
<source/>FEBS J
          <volume>275</volume>
<year>2008</year>
<fpage>16</fpage>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>
<source/>Cell
          <volume>120</volume>
<year>2005</year>
<fpage>15</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">15652477</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giraldez</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Cinalli</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Glasner</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Enright</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Baskerville</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Schier</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>MicroRNAs regulate brain morphogenesis in zebra fish</article-title>
<source/>Science
          <volume>308</volume>
<year>2005</year>
<fpage>833</fpage>
<lpage>838</lpage>
<pub-id pub-id-type="pmid">15774722</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girardot</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cavaille</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feil</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease</article-title>
<source/>Epigenetics
          <volume>7</volume>
<year>2012</year>
<fpage>1341</fpage>
<lpage>1348</lpage>
<pub-id pub-id-type="pmid">23154539</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Claus</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Plass</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Genome-wide epigenetic regulation of miRNAs in cancer</article-title>
<source/>Cancer Res
          <volume>73</volume>
<year>2013</year>
<fpage>473</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="pmid">23316035</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kala</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Peek</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Tollefsbol</surname>
<given-names>T.O.</given-names>
</name>
</person-group>
<article-title>MicroRNAs: an emerging science in cancer epigenetics</article-title>
<source/>J Clin Bioinforma
          <volume>3</volume>
<year>2013</year>
<fpage>6</fpage>
<pub-id pub-id-type="pmid">23497588</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>H.D.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Reik</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Epigenetic reprogramming in mammals</article-title>
<source/>Hum Mol Genet
          <volume>14</volume>
<issue>Suppl 1</issue>
<year>2005</year>
<fpage>R47</fpage>
<lpage>R58</lpage>
<pub-id pub-id-type="pmid">15809273</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Epigenetics in cancer</article-title>
<source/>Carcinogenesis
          <volume>31</volume>
<year>2010</year>
<fpage>27</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">19752007</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feinberg</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Vogelstein</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Hypomethylation distinguishes genes of some human cancers from their normal counterparts</article-title>
<source/>Nature
          <volume>301</volume>
<year>1983</year>
<fpage>89</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">6185846</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteller</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future</article-title>
<source/>Oncogene
          <volume>21</volume>
<year>2002</year>
<fpage>5427</fpage>
<lpage>5440</lpage>
<pub-id pub-id-type="pmid">12154405</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maehara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sugimachi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair</article-title>
<source/>Oncogene
          <volume>18</volume>
<year>1999</year>
<fpage>2143</fpage>
<lpage>2147</lpage>
<pub-id pub-id-type="pmid">10321739</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coppede</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Epigenetic biomarkers of colorectal cancer: focus on DNA methylation</article-title>
<source/>Cancer Lett
          <volume>342</volume>
<year>2014</year>
<fpage>238</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">22202641</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rideout</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Eversole-Cire</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Spruck</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Hustad</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Coetzee</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Progressive increases in the methylation status and hetero chromatinization of the myoD CpG island during oncogenic transformation</article-title>
<source/>Mol Cell Biol
          <volume>14</volume>
<year>1994</year>
<fpage>6143</fpage>
<lpage>6152</lpage>
<pub-id pub-id-type="pmid">8065347</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>Sharpless</surname>
<given-names>N.E.</given-names>
</name>
</person-group>
<article-title>The regulation of INK4/ARF in cancer and aging</article-title>
<source/>Cell
          <volume>127</volume>
<year>2006</year>
<fpage>265</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="pmid">17055429</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witcher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Emerson</surname>
<given-names>B.M.</given-names>
</name>
</person-group>
<article-title>Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary</article-title>
<source/>Mol Cell
          <volume>34</volume>
<year>2009</year>
<fpage>271</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">19450526</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Epigenetic activation of tumor suppressor microRNAs in human cancer cells</article-title>
<source/>Cell Cycle
          <volume> 5</volume>
<year>2006</year>
<fpage>2220</fpage>
<lpage>2222</lpage>
</element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veldic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Caruncho</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Satta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>101</volume>
<year>2004</year>
<fpage>348</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">14684836</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Botuyan</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Hammans</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hojo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamanishi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Karpf</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Boardman</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Cunningham</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Litchy</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Boes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Middha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>B Dyck</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Parisi</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Mer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D.I.</given-names>
</name>
<name>
<surname>Dyck</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Mutations in DNT1 cause hereditary sensory neuropathy with dementia and hearing loss</article-title>
<source/>Nat Genet
          <volume>43</volume>
<year>2011</year>
<fpage>595</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="pmid">21532572</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Bestor</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Bourc’his</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Tommerup</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bugge</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hulten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Viegas-Péquignot</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene</article-title>
<source/>Nature
          <volume>402</volume>
<year>1999</year>
<fpage>187</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">10647011</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mastroeni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McKee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grover</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>P.D.</given-names>
</name>
</person-group>
<article-title>Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease</article-title>
<source/>PLoS One
          <volume>4</volume>
<year>2009</year>
<fpage>e6617</fpage>
<pub-id pub-id-type="pmid">19672297</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mastroeni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Grover</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Delvaux</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Whiteside</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Epigenetic changes in Alzheimer's disease: decrements in DNA methylation</article-title>
<source/>Neurobiol Aging
          <volume>31</volume>
<year>2010</year>
<fpage>2025</fpage>
<lpage>2037</lpage>
<pub-id pub-id-type="pmid">19117641</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bollati</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Galimberti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pergoli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dalla Valle</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barretta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cortini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Scarpini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bertazzi</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Baccarelli</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>DNA methylation in repetitive elements and Alzheimer disease</article-title>
<source/>Brain Behav Immun
          <volume>25</volume>
<year>2011</year>
<fpage>1078</fpage>
<lpage>1083</lpage>
<pub-id pub-id-type="pmid">21296655</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Epigenetics: unfinished symphony</article-title>
<source/>Nature
          <volume>441</volume>
<year>2006</year>
<fpage>143</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="pmid">16688142</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burdge</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Lillycrop</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Slater-Jefferies</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition</article-title>
<source/>J Nutr
          <volume>139</volume>
<year>2009</year>
<fpage>1054</fpage>
<lpage>1060</lpage>
<pub-id pub-id-type="pmid">19339705</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jessberger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Clemenson</surname>
<given-names>G.D.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Mejia</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ure</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sinton</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>F.H.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Epigenetic modulation of seizure-induced neurogenesis and cognitive decline</article-title>
<source/>J Neurosci
          <volume>27</volume>
<year>2007</year>
<fpage>5967</fpage>
<lpage>5975</lpage>
<pub-id pub-id-type="pmid">17537967</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takayanagi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bielsky</surname>
<given-names>I.F.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Kawamata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Onaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yanagisawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matzuk</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Nishimori</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>102</volume>
<year>2005</year>
<fpage>16096</fpage>
<lpage>16101</lpage>
<pub-id pub-id-type="pmid">16249339</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Towers</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Biscocho</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Markunas</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Lintas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Abramson</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Langford</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Worley</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Delong</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Cuccaro</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Genomic and epigenetic evidence for oxytocin receptor deficiency in autism</article-title>
<source/>BMC Med
          <volume>7</volume>
<year>2009</year>
<fpage>62</fpage>
<pub-id pub-id-type="pmid">19845972</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.U.</given-names>
</name>
<name>
<surname>Kitabatake</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Pow-Anpongkul</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis</article-title>
<source/>Science
          <volume>323</volume>
<year>2009</year>
<fpage>1074</fpage>
<lpage>1077</lpage>
<pub-id pub-id-type="pmid">19119186</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraga</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Ballestar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Ropero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Setien</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ballestar</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Heine-Suñer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cigudosa</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Urioste</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Benitez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boix-Chornet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sanchez-Aguilera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vaag</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.Z.</given-names>
</name>
<name>
<surname>Plass</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Esteller</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Epigenetic differences arise during the lifetime of monozygotic twins</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>102</volume>
<year>2005</year>
<fpage>10604</fpage>
<lpage>10609</lpage>
<pub-id pub-id-type="pmid">16009939</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Isenberg</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Systemic lupus erythematosus</article-title>
<source/>N Engl J Med
          <volume>358</volume>
<year>2008</year>
<fpage>929</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="pmid">18305268</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D'Cruz</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Khamashta</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>G.R.</given-names>
</name>
</person-group>
<article-title>Systemic lupus erythematosus</article-title>
<source/>Lancet
          <volume>369</volume>
<year>2007</year>
<fpage>587</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="pmid">17307106</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis</article-title>
<source/>Scand J Rheumatol
          <volume>38</volume>
<year>2009</year>
<fpage>369</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="pmid">19444718</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Scheinbart</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Strahler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hanash</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis</article-title>
<source/>Arthritis Rheum
          <volume>33</volume>
<year>1990</year>
<fpage>1665</fpage>
<lpage>1673</lpage>
<pub-id pub-id-type="pmid">2242063</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mountz</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene</article-title>
<source/>J Exp Med
          <volume>178</volume>
<year>1993</year>
<fpage>461</fpage>
<lpage>468</lpage>
<pub-id pub-id-type="pmid">7688023</pub-id>
</element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation id="sref43" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizugaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishiwata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shindo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hishinuma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nozaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nose</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Alteration of DNA methylation levels in MRL lupus mice</article-title>
<source/>Clin Exp Immunol
          <volume>110</volume>
<year>1997</year>
<fpage>265</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">9367411</pub-id>
</element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Olorenshaw</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Kammer</surname>
<given-names>G.M.</given-names>
</name>
</person-group>
<article-title>Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>98</volume>
<year>2001</year>
<fpage>2628</fpage>
<lpage>2633</lpage>
<pub-id pub-id-type="pmid">11226290</pub-id>
</element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Maurer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Petri</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>K.E.</given-names>
</name>
</person-group>
<article-title>Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes</article-title>
<source/>Genes Immun
          <volume>11</volume>
<year>2010</year>
<fpage>124</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="pmid">19710693</pub-id>
</element-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation id="sref46" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duke</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Panayi</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Janossy</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Poulter</surname>
<given-names>L.W.</given-names>
</name>
</person-group>
<article-title>An immune histological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies</article-title>
<source/>Clin Exp Immunol
          <volume>49</volume>
<year>1982</year>
<fpage>22</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">6751631</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lefevre</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zimmermann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Muller-Ladner</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Rheumatoid arthritis progression mediated by activated synovial fibroblasts</article-title>
<source/>Trends Mol Med
          <volume>16</volume>
<year>2010</year>
<fpage>458</fpage>
<lpage>468</lpage>
<pub-id pub-id-type="pmid">20739221</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corvetta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Della Bitta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Luchetti</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Pomponio</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases</article-title>
<source/>J Chro- matogr
          <volume>566</volume>
<year>1991</year>
<fpage>481</fpage>
<lpage>491</lpage>
</element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation id="sref49" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neidhart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rethage</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuchen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kunzler</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Crowl</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Billingham</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Gay</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Gay</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression</article-title>
<source/>Arthritis Rheum
          <volume>43</volume>
<year>2000</year>
<fpage>2634</fpage>
<lpage>2647</lpage>
<pub-id pub-id-type="pmid">11145021</pub-id>
</element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation id="sref50" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karouzakis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gay</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Gay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Neidhart</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>DNA hypomethylation in rheumatoid arthritis synovial fibroblasts</article-title>
<source/>Arthritis Rheum
          <volume>60</volume>
<year>2009</year>
<fpage>3613</fpage>
<lpage>3622</lpage>
<pub-id pub-id-type="pmid">19950268</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maciejewska-Rodrigues</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Karouzakis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Strietholt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hemmatazad</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Neidhart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ospelt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gay</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Pap</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jüngel</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression</article-title>
<source/>J Autoimmun
          <volume>35</volume>
<year>2010</year>
<fpage>15</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">20079608</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Storgaard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Madsbad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Vaag</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weight</article-title>
<source/>J Clin Endocrinol Metab
          <volume>92</volume>
<year>2007</year>
<fpage>1530</fpage>
<lpage>1534</lpage>
<pub-id pub-id-type="pmid">17284623</pub-id>
</element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozanne</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Tingey</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Storgaard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Madsbad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vaag</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Low birthweight is associated with specific changes in muscle insulin-signalling protein expression</article-title>
<source/>Diabetologia
          <volume>48</volume>
<year>2005</year>
<fpage>547</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="pmid">15729577</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation id="sref54" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozanne</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Tingey</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Martin-Gronert</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Grunnet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brons</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Storgaard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vaag</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight: potential link to increased risk of diabetes?</article-title>
<source/>Diabetologia
          <volume>49</volume>
<year>2006</year>
<fpage>2993</fpage>
<lpage>2999</lpage>
<pub-id pub-id-type="pmid">17063325</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poulsen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vaag</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The intrauterine environment as reflected by birth size and twin and zygosity status influences insulin action and intracellular glucose metabolism in an age- or time-dependent manner</article-title>
<source/>Diabetes
          <volume>55</volume>
<year>2006</year>
<fpage>1819</fpage>
<lpage>1825</lpage>
<pub-id pub-id-type="pmid">16731848</pub-id>
</element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>The developmental origins of insulin resistance</article-title>
<source/>Horm Res
          <volume>64</volume>
<year>2005</year>
<fpage>2</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">16439838</pub-id>
</element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation id="sref57" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tobi</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Lumey</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Talens</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Kremer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Slagboom</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Heijmans</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>DNA Methylation differences after exposure to prenatal famine are common and timing- and sex-specific</article-title>
<source/>Hum Mol Genet
          <volume>18</volume>
<year>2009</year>
<fpage>4046</fpage>
<lpage>4053</lpage>
<pub-id pub-id-type="pmid">19656776</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heijmans</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Tobi</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Blauw</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Susser</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Slagboom</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Lumey</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>Persistent epigenetic differences associated with prenatal exposure to famine in humans</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>105</volume>
<year>2008</year>
<fpage>17046</fpage>
<lpage>17049</lpage>
<pub-id pub-id-type="pmid">18955703</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Todorov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ku</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Al-Abdullah</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Kandeel</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mullen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Ferreri</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Insulin gene expression is regulated by DNA methylation</article-title>
<source/>PLoS One
          <volume>4</volume>
<year>2009</year>
<fpage>e6953</fpage>
<pub-id pub-id-type="pmid">19742322</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mutskov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Felsenfeld</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The human insulin gene is part of a large open chromatin domain specific for human islets</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>106</volume>
<year>2009</year>
<fpage>17419</fpage>
<lpage>17424</lpage>
<pub-id pub-id-type="pmid">19805079</pub-id>
</element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mutskov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Raaka</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Felsenfeld</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gershengorn</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression</article-title>
<source/>Stem Cells
          <volume>25</volume>
<year>2007</year>
<fpage>3223</fpage>
<lpage>3233</lpage>
<pub-id pub-id-type="pmid">17901401</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholls</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Knepper</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Genome organization, function, and imprinting in Prader–Willi and Angelman syndromes</article-title>
<source/>Annu Rev Genomics Hum Genet
          <volume>2</volume>
<year>2001</year>
<fpage>153</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">11701647</pub-id>
</element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weksberg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Squire</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sadowski</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Beckwith–Wiedemann syndrome demonstrates a role for epigenetic control of normal development</article-title>
<source/>Hum Mol Genet
          <volume>12</volume>
<year>2003</year>
<fpage>R61</fpage>
<lpage>R68</lpage>
<pub-id pub-id-type="pmid">12668598</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hitchins</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Stanier</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Preece</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>Silver–Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions</article-title>
<source/>J Med Genet
          <volume>38</volume>
<year>2001</year>
<fpage>810</fpage>
<lpage>819</lpage>
<pub-id pub-id-type="pmid">11748303</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<label>65</label>
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamnasaran</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Current status of human chromosome 14</article-title>
<source/>J Med Genet
          <volume>39</volume>
<year>2002</year>
<fpage>81</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">11836355</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<label>66</label>
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verona</surname>
<given-names>R.I.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Bartolomei</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Genomic imprinting: intricacies of epigenetic regulation in clusters</article-title>
<source/>Annu Rev Cell Dev Biol
          <volume>19</volume>
<year>2003</year>
<fpage>237</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="pmid">14570570</pub-id>
</element-citation>
</ref>
<ref id="bib67">
<label>67</label>
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Rogan</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Buiting</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Saitoh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Muralidhar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bilienska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Krajewska-Walasek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Horsthemke</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Imprinting-mutation mechanisms in PradereWilli syndrome</article-title>
<source/>Am J Hum Genet
          <volume>64</volume>
<year>1999</year>
<fpage>397</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="pmid">9973278</pub-id>
</element-citation>
</ref>
<ref id="bib68">
<label>68</label>
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahoo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>del</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>German</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Shinawi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>S.U.</given-names>
</name>
<name>
<surname>Person</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Garnica</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Pradere Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster</article-title>
<source/>Nat Genet
          <volume>40</volume>
<year>2008</year>
<fpage>719</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="pmid">18500341</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<label>69</label>
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buiting</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gillessen-Kaesbach</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>el-Maarri</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Horsthemke</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Epimutations in PradereWilli and Angelman syndromes: a molecular study of 136 patients with an imprinting defect</article-title>
<source/>Am J Hum Genet
          <volume>72</volume>
<year>2003</year>
<fpage>571</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="pmid">12545427</pub-id>
</element-citation>
</ref>
<ref id="bib70">
<label>70</label>
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buiting</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Barnicoat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pembrey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Malcolm</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Horsthemke</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Disruption of the bipartite imprinting center in a family with Angelman syndrome</article-title>
<source/>Am J Hum Genet
          <volume>68</volume>
<year>2001</year>
<fpage>1290</fpage>
<lpage>1294</lpage>
<pub-id pub-id-type="pmid">11283796</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<label>71</label>
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lalande</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wagstaff</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>UBE3A/E6-AP mutations cause Angelman syndrome</article-title>
<source/>Nat Genet
          <volume>15</volume>
<year>1997</year>
<fpage>70</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">8988171</pub-id>
</element-citation>
</ref>
<ref id="bib72">
<label>72</label>
<element-citation id="sref72" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteller</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>DNA methylation and Cancer therapy: new developments and expectations</article-title>
<source/>Curr Opin Oncol
          <volume>17</volume>
<year>2005</year>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">15608514</pub-id>
</element-citation>
</ref>
<ref id="bib73">
<label>73</label>
<element-citation id="sref73" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Issa</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Kantarjian</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Kirkpatrick</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Azacitidine</article-title>
<source/>Nat Rev Drug Discov
          <volume>4</volume>
<year>2005</year>
<fpage>275</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="pmid">15861567</pub-id>
</element-citation>
</ref>
<ref id="bib74">
<label>74</label>
<element-citation id="sref74" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodenhiser</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Epigenetics and human disease: translating basic biology into clinical applications</article-title>
<source/>CMAJ
          <volume>174</volume>
<year>2006</year>
<fpage>341</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">16446478</pub-id>
</element-citation>
</ref>
<ref id="bib75">
<label>75</label>
<element-citation id="sref75" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egger</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Aparicio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Epigenetics in human disease and prospects for epigenetic therapy</article-title>
<source/>Nature
          <volume>429</volume>
<year>2004</year>
<fpage>457</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="pmid">15164071</pub-id>
</element-citation>
</ref>
<ref id="bib76">
<label>76</label>
<element-citation id="sref76" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mongomery</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Paik</surname>
<given-names>H.I.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Nephew</surname>
<given-names>K.P.</given-names>
</name>
</person-group>
<article-title>New anti-cancer strategies: epigenetic therapies and biomarkers</article-title>
<source/>Front Biosci
          <volume>10</volume>
<year>2005</year>
<fpage>1897</fpage>
<lpage>1931</lpage>
<pub-id pub-id-type="pmid">15769674</pub-id>
</element-citation>
</ref>
<ref id="bib77">
<label>77</label>
<element-citation id="sref77" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mongan</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Gudas</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells</article-title>
<source/>Mol Cancer Ther
          <volume>4</volume>
<year>2005</year>
<fpage>477</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="pmid">15767557</pub-id>
</element-citation>
</ref>
</ref-list>
<fn-group>
<fn id="d31e14">
<p id="ntpara0010">Peer review under responsibility of Taibah University.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>